IRIS
DALLIO, MARCELLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.680
AS - Asia 1.366
NA - Nord America 918
SA - Sud America 259
AF - Africa 20
OC - Oceania 6
Totale 4.249
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 881
RU - Federazione Russa 839
SG - Singapore 506
IT - Italia 365
CN - Cina 321
IE - Irlanda 240
BR - Brasile 210
HK - Hong Kong 197
KR - Corea 97
VN - Vietnam 77
JP - Giappone 73
DE - Germania 71
GB - Regno Unito 46
IN - India 42
FR - Francia 24
AR - Argentina 23
AT - Austria 18
FI - Finlandia 17
NL - Olanda 17
CA - Canada 16
MX - Messico 14
GR - Grecia 12
EC - Ecuador 10
ID - Indonesia 10
PK - Pakistan 9
ZA - Sudafrica 9
BD - Bangladesh 7
AU - Australia 6
IQ - Iraq 6
PY - Paraguay 6
EG - Egitto 5
ES - Italia 5
PL - Polonia 5
SE - Svezia 5
KZ - Kazakistan 4
PE - Perù 4
UZ - Uzbekistan 4
CO - Colombia 3
CZ - Repubblica Ceca 3
LK - Sri Lanka 3
MK - Macedonia 3
UA - Ucraina 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
BE - Belgio 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
IR - Iran 2
KG - Kirghizistan 2
LT - Lituania 2
TR - Turchia 2
AM - Armenia 1
AO - Angola 1
BS - Bahamas 1
CR - Costa Rica 1
ET - Etiopia 1
HN - Honduras 1
IM - Isola di Man 1
JM - Giamaica 1
JO - Giordania 1
MA - Marocco 1
NO - Norvegia 1
PT - Portogallo 1
SC - Seychelles 1
TT - Trinidad e Tobago 1
Totale 4.249
Salva come PNG Salva come JPEG
Città #
Moscow 293
Dublin 238
Singapore 232
Hong Kong 194
Santa Clara 161
Chandler 108
Naples 104
Seoul 97
Hefei 76
Beijing 68
Ashburn 56
New York 54
Ho Chi Minh City 32
Dallas 30
Boardman 28
Bengaluru 27
Princeton 26
Roxbury 25
Munich 22
Bremen 21
Cambridge 21
São Paulo 21
Hanoi 18
Los Angeles 18
The Dalles 18
Nuremberg 16
Caserta 14
Aversa 13
Rome 13
Vienna 12
Amsterdam 11
Boydton 10
Paris 9
Salerno 9
Des Moines 8
Mexico City 8
Tokyo 8
Falkenstein 7
Medford 7
San Francisco 7
Turku 7
Belo Horizonte 6
Brooklyn 6
Castellammare di Stabia 6
Sennori 6
Viterbo 6
Boston 5
Brasília 5
Helsinki 5
Lappeenranta 5
Warsaw 5
Camerino 4
Chengdu 4
Curitiba 4
Groningen 4
Guangzhou 4
Houston 4
Hyderabad 4
Manaus 4
Milan 4
Quito 4
Rio de Janeiro 4
Shanghai 4
Sialkot 4
Tashkent 4
Tianjin 4
Wilmington 4
Astana 3
Asunción 3
Baghdad 3
Bauru 3
Bisaccia 3
Brno 3
Changsha 3
Colombo 3
Cusco 3
Da Nang 3
Jacksonville 3
Jaraguá do Sul 3
Jinan 3
Johannesburg 3
Lodi 3
Manassas 3
Melbourne 3
Minya 3
Montreal 3
Mumbai 3
Ninh Bình 3
Osasco 3
Porto Alegre 3
Stockholm 3
Taiyuan 3
Toronto 3
Zola Predosa 3
Albanella 2
Atlanta 2
Betim 2
Bexley 2
Bishkek 2
Biên Hòa 2
Totale 2.359
Salva come PNG Salva come JPEG
Nome #
Integrating Silybin and Sirtuin Related Pathways in Steatosis-Related Liver Diseases 144
Adherence and Effects Derived from FODMAP Diet on Irritable Bowel Syndrome: A Real Life Evaluation of a Large Follow-Up Observation 117
A 60-Year-Old Woman with Primary Biliary Cholangitis and Crohn's Ileitis Following the Suspension of Ursodeoxycholic Acid 108
May chronic cough in chronic obstructive pulmonary disease be a contraindication of Percutaneous Endoscopic Gastrostomy placement: a case report 107
The bisphenol a induced oxidative stress in non-alcoholic fatty liver disease male patients: A clinical strategy to antagonize the progression of the disease 102
The Lesson from the First Italian Lockdown: Impacts on Anxiety and Depressive Symptoms and Sleep Quality in Patients with Remission of Inflammatory Bowel Disease 98
Gut microbiota correlates with antitumor activity in patients with mCRC and NSCLC treated with cetuximab plus avelumab 93
Alcoholic Consumption of Young Italians During the SARS-CoV-2 Pandemic 91
The urotensin-II receptor: A marker for staging and steroid outcome prediction in ulcerative colitis 88
Non-bismuth and bismuth quadruple therapies based on previous clarithromycin exposure are as effective and safe in an area of high clarithromycin resistance: A real-life study 88
Urotensin II receptor expression in patients with ulcerative colitis: a pilot study 88
Inflammatory Bowel Diseases: The Role of Gut Microbiota 88
Light alcohol drinking and the risk of cancer development: a controversial relationship 87
Alcohol associated liver disease 2020: A clinical practice guideline by the Italian Association for the Study of the Liver (AISF) 86
The analysis of alcohol consumption during the severe acute respiratory syndrome coronavirus 2 Italian lockdown 85
How immunotherapy has changed the continuum of care in hepatocellular carcinoma 84
Beneficial Effects of Silybin Treatment After Viral Eradication in Patients With HCV-Related Advanced Chronic Liver Disease: A Pilot Study 80
Clinical features and comorbidity pattern of HCV infected migrants compared to native patients in care in Italy: A real-life evaluation of the PITER cohort 78
Nutrigenomics and nutrigenetics in metabolic-(Dysfunction) associated fatty liver disease: Novel insights and future perspectives 77
The Melanocortin System in Inflammatory Bowel Diseases: Insights into Its Mechanisms and Therapeutic Potentials 75
On-treatment serum albumin level can guide long-term treatment in patients with cirrhosis and uncomplicated ascites 74
Development of a risk score to predict portal vein tumor thrombosis in patients with hepatocellular carcinoma 72
Role of Non-Coding RNAs in Hepatocellular Carcinoma Progression: From Classic to Novel Clinicopathogenetic Implications 72
PNPLA3, TM6SF2, and MBOAT7 Influence on Nutraceutical Therapy Response for Non-alcoholic Fatty Liver Disease: A Randomized Controlled Trial 72
Risk factors for liver decompensation and hcc in hcv-cirrhotic patients after daas: A multicenter prospective study 71
Intestinal pseudo-obstruction as systemic lupus erythematosus complication: is it time to reconsider the role of surgery? A case report of a tailored multidisciplinary managed 44-year-old male patient 70
The Role of Insulin Resistance in Fueling NAFLD Pathogenesis: From Molecular Mechanisms to Clinical Implications 69
Trends in chronic hepatitis B virus infection in Italy over a 10-year period: Clues from the nationwide PITER and MASTER cohorts toward elimination 68
FLAME: Training and Validating a Newly Conceived Model Incorporating Alpha-Glutathione-S-Transferase Serum Levels for Predicting Advanced Hepatic Fibrosis and Acute Cardiovascular Events in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) 67
Cirrhosis and frailty assessment in elderly patients: A paradoxical result 66
Urinary volatile Organic compounds in non-alcoholic fatty liver disease (NAFLD), type two diabetes mellitus (T2DM) and NAFLD-T2DM coexistence 65
Immunity as cornerstone of non-alcoholic fatty liver disease: The contribution of oxidative stress in the disease progression 65
Red cell distribution width/platelet ratio estimates the 3-year risk of decompensation in Metabolic Dysfunction-Associated Steatotic Liver Disease-induced cirrhosis 65
Dysgeusia in MASLD-related advanced chronic liver disease (ACLD): a silent driver towards the "Bermuda" triangle of malnutrition-sarcopenia-frailty severely affecting prognosis 64
Critical review on the use and abuse of alcohol. When the dose makes the difference 64
Extra-Gastric Manifestations of Helicobacter pylori Infection 64
Environmental bisphenol A exposure triggers trained immunity-related pathways in monocytes 63
Systemic Oxidative Balance Reflects the Liver Disease Progression Status for Primary Biliary Cholangitis (Pbc): The Narcissus Fountain 63
Performance of the model for end-stage liver disease score for mortality prediction and the potential role of etiology 63
Further decompensation in cirrhosis: Results of a large multicenter cohort study supporting Baveno VII statements 62
The role of resveratrol in liver disease: A comprehensive review from in vitro to clinical trials 60
Exploring the Classic and Novel Pathogenetic Insights of Plastic Exposure in the Genesis and Progression of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) 59
The role of fructose in non-alcoholic steatohepatitis: Old relationship and new insights 58
Is it time to reconsider the MRP6 role in bile secretion and LPAC genetic signature? 57
Clinical Applications of Artificial Intelligence (AI) in Human Cancer: Is It Time to Update the Diagnostic and Predictive Models in Managing Hepatocellular Carcinoma (HCC)? 55
Systemic Oxidative Stress Correlates with Sarcopenia and Pruritus Severity in Primary Biliary Cholangitis (PBC): Two Independent Relationships Simultaneously Impacting the Quality of Life—Is the Low Absorption of Cholestasis-Promoted Vitamin D a Puzzle Piece? 52
Predicting de‐novo portal vein thrombosis after HCV eradication: A long‐term competing risk analysis in the ongoing PITER cohort 51
Spleen Area Affects the Performance of the Platelet Count–Based Non-invasive Tools in Predicting First Hepatic Decompensation in Metabolic Dysfunction–Associated Steatotic Liver Disease Cirrhosis 49
Untargeted metabolomics as a diagnostic tool in NAFLD: discrimination of steatosis, steatohepatitis and cirrhosis 49
Interaction between estrogen receptor-α and PNPLA3 p.I148M variant drives fatty liver disease susceptibility in women 49
The influence of acute lifestyle changes on NAFLD evolution in a multicentre cohort: a matter of body composition 48
The Role of Cytokines in the Pathogenesis and Treatment of Alcoholic Liver Disease 47
Letter: Different Risk of Acute Variceal Bleeding According to the Liver Disease Aetiology in Decompensated Cirrhosis Patients Receiving Carvedilol‐Based Primary Prophylaxis—May Insulin Resistance Unloose This Gordian Knot? 47
Nutritional and Psychological Support as a Multidisciplinary Coordinated Approach in the Management of Chronic Liver Disease: A Scoping Review 45
Reduction of the Risk of Hepatocellular Carcinoma over Time Using Direct-Acting Antivirals: A Propensity Score Analysis of a Real-Life Cohort (PITER HCV) 42
The Role of the Gut–Biliary–Liver Axis in Primary Hepatobiliary Liver Cancers: From Molecular Insights to Clinical Applications 42
Primary biliary cholangitis, Celiac Disease, and MASLD: the triumvirate of steatosis. How should we manage this triple overlap? 40
Recovery of Bacteroides thetaiotaomicron ameliorates hepatic steatosis in experimental alcohol-related liver disease 38
The Medical Impact of Hepatitis D Virus Infection in Natives and Immigrants: The Italian Paradigm 38
From “Traditional” to “Trained” Immunity: Exploring the Novel Frontiers of Immunopathogenesis in the Progression of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) 37
Long-term albumin improves the outcomes of patients with decompensated cirrhosis and diabetes mellitus: Post hoc analysis of the ANSWER trial 37
Exploring the Epidemiologic Burden, Pathogenetic Features, and Clinical Outcomes of Primary Liver Cancer in Patients with Type 2 Diabetes Mellitus (T2DM) and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Scoping Review 36
Safety of Sofosbuvir-Based Direct-Acting Antivirals for Hepatitis C Virus Infection and Direct Oral Anticoagulant Co-Administration 35
Dimethyl fumarate ameliorates hepatic inflammation in alcohol related liver disease 35
Phase Angle/C-reactive Protein-Index as a Novel Combined Tool for Predicting Liver-Related Hospitalizations in MASLD-Decompensated Cirrhosis 29
Beneficial Effects of Long-Lasting Bicarbonate–Sulfate–Calcium–Magnesium Water Intake on Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)-Related Outcomes via Impacting Intestinal Permeability (IP), IP-Related Systemic Inflammation, and Oxidative Stress 20
Managing Ascites and Kidney Dysfunction in Decompensated Advanced Chronic Liver Disease: From “One Size Fits All” to a Multidisciplinary-Tailored Approach 18
Totale 4.376
Salva come PNG Salva come JPEG
Categoria #
all - tutte 17.179
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.179
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202173 0 0 0 0 0 1 16 6 8 12 24 6
2021/2022201 1 9 8 22 35 15 7 3 6 11 31 53
2022/2023520 39 13 14 37 84 31 0 26 245 7 10 14
2023/2024382 23 10 12 22 59 62 13 1 21 35 40 84
2024/20251.016 6 17 20 46 155 106 140 100 117 126 96 87
2025/20262.135 223 355 279 212 466 600 0 0 0 0 0 0
Totale 4.376